Sun Pharma Advanced Research Co Ltd (NSE:SPARC) Share Price

Company Profile

Business description
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.
Contact
Off Mahakali Caves Road
17-B, Mahal Industrial Estate
Andheri (East)
MumbaiMH400093
IND
T: +91 2266455645
https://www.sparc.life
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2025
Employees
603

Recommended

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Matt Wacher | 21 February 2025

We’ve upgraded our fair value estimate for 29 companies, or 40% of those that have reported thus far.

Lochlan Halloway | 20 February 2025

Our analysts think these companies are undervalued and their shares appear to have the stamp of approval from highly rated managers.

Joseph Taylor | 20 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,570.90	30.80	-0.36%
CAC 40	8,154.51	31.93	0.39%
DAX 40	22,287.56	27.09	-0.12%
Dow JONES (US)	43,493.51	683.14	-1.55%
FTSE 100	8,659.37	3.60	-0.04%
HKSE	23,477.92	900.94	3.99%
NASDAQ	19,644.06	318.30	-1.59%
Nikkei 225	38,776.94	98.90	0.26%
NZX 50 Index	12,752.58	127.78	-0.99%
S&P 500	6,036.09	81.43	-1.33%
S&P/ASX 200	8,296.20	26.60	-0.32%
SSE Composite Index	3,379.11	28.33	0.85%